Economic benefit analysis of primary prevention with pravastatin. Assumptions are methodologically flawed.
Freemantle
N
N
Mason
J
J
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D003327:Coronary Disease / Q000517:prevention & control*; D003625:Data Collection / Q000592:standards; D006801:Humans; D017035:Pravastatin / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D017035:Pravastatin